FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME
The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, partic...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Boscheinen, Oliver Langer, Thomas Dreyer, Matthias Schaefer, Hans-Ludwig Sommerfeld, Mark Habermann, Paul |
| description | The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019085043A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019085043A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019085043A13</originalsourceid><addsrcrecordid>eNrjZDB0Cw329PdTCAjyD3H19AtWcPMPUggJcnUM8fRzV3BU8HUNcXTy9_F0VgiO9HMJ8vd15WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlgYWpgYmxo6GxsSpAgD9SCeb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME</title><source>esp@cenet</source><creator>Boscheinen, Oliver ; Langer, Thomas ; Dreyer, Matthias ; Schaefer, Hans-Ludwig ; Sommerfeld, Mark ; Habermann, Paul</creator><creatorcontrib>Boscheinen, Oliver ; Langer, Thomas ; Dreyer, Matthias ; Schaefer, Hans-Ludwig ; Sommerfeld, Mark ; Habermann, Paul</creatorcontrib><description>The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190321&DB=EPODOC&CC=US&NR=2019085043A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190321&DB=EPODOC&CC=US&NR=2019085043A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Boscheinen, Oliver</creatorcontrib><creatorcontrib>Langer, Thomas</creatorcontrib><creatorcontrib>Dreyer, Matthias</creatorcontrib><creatorcontrib>Schaefer, Hans-Ludwig</creatorcontrib><creatorcontrib>Sommerfeld, Mark</creatorcontrib><creatorcontrib>Habermann, Paul</creatorcontrib><title>FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME</title><description>The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB0Cw329PdTCAjyD3H19AtWcPMPUggJcnUM8fRzV3BU8HUNcXTy9_F0VgiO9HMJ8vd15WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlgYWpgYmxo6GxsSpAgD9SCeb</recordid><startdate>20190321</startdate><enddate>20190321</enddate><creator>Boscheinen, Oliver</creator><creator>Langer, Thomas</creator><creator>Dreyer, Matthias</creator><creator>Schaefer, Hans-Ludwig</creator><creator>Sommerfeld, Mark</creator><creator>Habermann, Paul</creator><scope>EVB</scope></search><sort><creationdate>20190321</creationdate><title>FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME</title><author>Boscheinen, Oliver ; Langer, Thomas ; Dreyer, Matthias ; Schaefer, Hans-Ludwig ; Sommerfeld, Mark ; Habermann, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019085043A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Boscheinen, Oliver</creatorcontrib><creatorcontrib>Langer, Thomas</creatorcontrib><creatorcontrib>Dreyer, Matthias</creatorcontrib><creatorcontrib>Schaefer, Hans-Ludwig</creatorcontrib><creatorcontrib>Sommerfeld, Mark</creatorcontrib><creatorcontrib>Habermann, Paul</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Boscheinen, Oliver</au><au>Langer, Thomas</au><au>Dreyer, Matthias</au><au>Schaefer, Hans-Ludwig</au><au>Sommerfeld, Mark</au><au>Habermann, Paul</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME</title><date>2019-03-21</date><risdate>2019</risdate><abstract>The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2019085043A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T22%3A58%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Boscheinen,%20Oliver&rft.date=2019-03-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019085043A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |